CASE REPORT
Published on 03 Feb 2025
Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report
doi 10.3389/fonc.2025.1385794
- 565 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Advancements and Cutting-Edge Approaches to Counteract the Inefficacy of Immune Checkpoint Inhibitor Therapies in Lung Cancer
Advancements and Cutting-Edge Approaches to Counteract the Inefficacy of Immune Checkpoint Inhibitor Therapies in Lung Cancer
10k
Total downloads
28k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 18 Oct 2024
Heterogeneity between subgroups of first-line chemoimmunotherapy for extensive-stage small cell lung cancer patients: a meta-analysis and systematic review
doi 10.3389/fonc.2024.1334957
- 708 views
ORIGINAL RESEARCH
Published on 09 Aug 2024
Construction of a risk prediction model for lung infection after chemotherapy in lung cancer patients based on the machine learning algorithm
doi 10.3389/fonc.2024.1403392
- 3,804 views
- 2 citations
ORIGINAL RESEARCH
Published on 05 Jul 2024
Immune checkpoint inhibitor increased mortality in lung cancer patients with Pneumocystis jirovecii pneumonia: a comparative retrospective cohort study
doi 10.3389/fonc.2024.1398357
- 966 views
- 2 citations
REVIEW
Published on 05 Jun 2024
Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors
doi 10.3389/fimmu.2024.1384121
- 2,648 views
- 9 citations
SYSTEMATIC REVIEW
Published on 16 May 2024
Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis
doi 10.3389/fonc.2024.1385761
- 1,512 views
SYSTEMATIC REVIEW
Published on 08 May 2024
Association between immune-related adverse events and prognosis in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
doi 10.3389/fonc.2024.1402017
- 998 views
- 2 citations
CASE REPORT
Published on 23 Apr 2024
ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case report
doi 10.3389/fonc.2024.1395654
- 1,139 views
- 2 citations
ORIGINAL RESEARCH
Published on 18 Apr 2024
Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors
doi 10.3389/fimmu.2024.1332303
- 1,372 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Feb 2024
MicroRNA-126 selected with broad-spectrum analysis of microRNAs – a new predictive factor for the effectiveness of immunotherapy or chemoimmunotherapy in advanced NSCLC patients?
doi 10.3389/fimmu.2024.1344858
- 1,386 views
- 2 citations
ORIGINAL RESEARCH
Published on 26 Jan 2024
Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study
doi 10.3389/fonc.2024.1303543
- 1,131 views
CASE REPORT
Published on 12 Jan 2024
Case report: Checkpoint inhibitor pneumonitis with positive anti-melanoma differentiation-associated gene 5 antibodies in a patient with lung cancer
doi 10.3389/fimmu.2023.1309531
- 1,171 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore